Kathryn M. Lemberg

17.9k total citations · 1 hit paper
18 papers, 13.2k citations indexed

About

Kathryn M. Lemberg is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kathryn M. Lemberg has authored 18 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Kathryn M. Lemberg's work include Neuroblastoma Research and Treatments (6 papers), Neurofibromatosis and Schwannoma Cases (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Kathryn M. Lemberg is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Neurofibromatosis and Schwannoma Cases (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Kathryn M. Lemberg collaborates with scholars based in United States, Czechia and Canada. Kathryn M. Lemberg's co-authors include Andras J. Bauer, Brent R. Stockwell, Caroline E. Gleason, Rachid Skouta, Barclay Morrison, Scott J. Dixon, Alexandra M. Cantley, Wan Seok Yang, Michael R. Lamprecht and Barbara S. Slusher and has published in prestigious journals such as Cell, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Kathryn M. Lemberg

16 papers receiving 13.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

2012 12.8k citations Scott J. Dixon, Kathryn M. Lemberg et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn M. Lemberg United States	7	7.9k	7.6k	5.5k	1.3k	1.1k	18	13.2k
Alexandra M. Cantley United States	7	7.8k 1.0×	7.6k 1.0×	5.3k 1.0×	1.3k 1.0×	1.0k 0.9×	7	13.0k
Caroline E. Gleason United States	6	9.0k 1.1×	8.8k 1.2×	6.3k 1.1×	1.6k 1.2×	1.1k 1.0×	6	14.8k
Andras J. Bauer United States	8	8.7k 1.1×	8.5k 1.1×	6.0k 1.1×	1.4k 1.1×	1.1k 1.0×	9	14.2k
Xin Chen China	47	9.3k 1.2×	8.5k 1.1×	6.0k 1.1×	2.1k 1.6×	1.3k 1.2×	255	15.9k
Boyi Gan United States	56	11.9k 1.5×	8.9k 1.2×	8.3k 1.5×	1.8k 1.4×	1.1k 1.0×	107	17.4k
Rachid Skouta United States	29	14.0k 1.8×	14.1k 1.8×	9.9k 1.8×	2.5k 1.9×	1.7k 1.5×	53	23.9k
Li Zhuang China	35	5.5k 0.7×	5.1k 0.7×	3.9k 0.7×	1.4k 1.1×	626 0.6×	101	9.0k
Vasanthi S. Viswanathan United States	7	5.0k 0.6×	5.2k 0.7×	3.7k 0.7×	969 0.7×	559 0.5×	10	7.7k
Marcus Conrad Germany	68	14.6k 1.8×	13.0k 1.7×	9.3k 1.7×	2.2k 1.7×	1.9k 1.8×	146	24.4k
Andreas Linkermann Germany	54	9.2k 1.2×	4.3k 0.6×	3.2k 0.6×	1.4k 1.0×	3.2k 2.9×	104	14.7k

Countries citing papers authored by Kathryn M. Lemberg

Since Specialization

Citations

This map shows the geographic impact of Kathryn M. Lemberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn M. Lemberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn M. Lemberg more than expected).

Fields of papers citing papers by Kathryn M. Lemberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn M. Lemberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn M. Lemberg. The network helps show where Kathryn M. Lemberg may publish in the future.

Co-authorship network of co-authors of Kathryn M. Lemberg

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn M. Lemberg. A scholar is included among the top collaborators of Kathryn M. Lemberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn M. Lemberg. Kathryn M. Lemberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rahnama, Ruyan, Kathryn M. Lemberg, Jason Fixler, et al.. (2024). Brain Metastasis in Pediatric Patients with Osteosarcoma. Current Oncology. 31(11). 7014–7022. 1 indexed citations

Lemberg, Kathryn M., Andrea M. Gross, David J. Liewehr, et al.. (2024). Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment. Pediatric Research. 97(6). 1918–1928. 1 indexed citations

Larman, Tatianna, Kiyoko Oshima, Daniel S. Rhee, et al.. (2024). Liver transplant for primary biliary tract neuroendocrine tumor in a nine‐year‐old girl. Pediatric Transplantation. 28(2). e14732–e14732.

Lemberg, Kathryn M., Ravi Varadhan, Alan Siegel, et al.. (2023). Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors. Neuro-Oncology Advances. 5(1). vdad156–vdad156.

Lemberg, Kathryn M., Eunüs S. Ali, Marcela Krečmerová, et al.. (2023). Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 22(12). 1390–1403. 1 indexed citations

Zou, Ying, Laura Morsberger, Jaclyn B. Murry, et al.. (2023). Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas. Genes. 14(6). 1139–1139. 3 indexed citations

Rais, Rana, Kathryn M. Lemberg, Lukáš Tenora, et al.. (2022). Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances. 8(46). eabq5925–eabq5925. 77 indexed citations

Lemberg, Kathryn M., David James Young, Allen Chen, et al.. (2022). Trainee-led Engagement of the Care Team Improves Application of an Institutional Blood Culture Clinical Decision Algorithm to Pediatric Oncology Inpatients: A Single-institution Quality Improvement Project. Pediatric Quality and Safety. 7(2). e545–e545. 1 indexed citations

Alt, Jesse, Kathryn M. Lemberg, Arindom Pal, et al.. (2021). Glutamine Antagonist GA-607 Causes a Dramatic Accumulation of FGAR which can be used to Monitor Target Engagement. Current Drug Metabolism. 22(9). 735–745. 3 indexed citations

10.

Lemberg, Kathryn M., Jiawan Wang, & Christine A. Pratilas. (2020). From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor. Genes. 11(6). 691–691. 32 indexed citations

11.

Lemberg, Kathryn M., Liang Zhao, Ying Wu, et al.. (2019). The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 19(2). 397–408. 16 indexed citations

12.

Tenora, Lukáš, Jesse Alt, Ranjeet Prasad Dash, et al.. (2019). Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. Journal of Medicinal Chemistry. 62(7). 3524–3538. 48 indexed citations

13.

Lemberg, Kathryn M., Ying Wu, Jesse Alt, et al.. (2018). Abstract 3524: Novel prodrugs of the glutamine antagonist 6-diazo-5-oxo-norleucine (DON) as treatment for malignant peripheral nerve sheath tumor. Cancer Research. 78(13_Supplement). 3524–3524. 1 indexed citations

14.

Lemberg, Kathryn M., James J. Vornov, Rana Rais, & Barbara S. Slusher. (2018). We're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of6-Diazo-5-oxo-L-norleucine. Molecular Cancer Therapeutics. 17(9). 1824–1832. 167 indexed citations

15.

Dixon, Scott J., Kathryn M. Lemberg, Michael R. Lamprecht, et al.. (2012). Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell. 149(5). 1060–1072. 12762 indexed citations breakdown →

16.

Lemberg, Kathryn M.. (2011). Ferroptosis: A Novel Form of Cancer Cell Death Induced by the Small Molecule Erastin. Columbia Academic Commons (Columbia University). 2 indexed citations

17.

Bauer, Andras J., et al.. (2011). Functional Model of Metabolite Gating by Human Voltage-Dependent Anion Channel 2. Biochemistry. 50(17). 3408–3410. 29 indexed citations

18.

Lemberg, Kathryn M., et al.. (2007). The Dynamic Mu Transpososome: MuB Activation Prevents Disintegration. Journal of Molecular Biology. 374(5). 1158–1171. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact